Skip to main content
Log in

Influence of input rates on (±)-isradipine haemodynamics and concentration-effect relationship in healthy volunteers

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

Since the magnitude of the response to a drug may depend upon the drug input rate, the concentration-effect relationship of the new dihydropyridine (±)-isradipine was investigated using different administration modalities.

Ten normotensive healthy volunteers were given, double-blind and in a crossover fashion, isradipine as a 1 mg iv infusion, 5 mg oral solution, 5 mg standard tablet, 10 mg slow release formulation, and a placebo. Blood pressure, heart rate, and plasma isradipine concentrations were recorded for 24 h.

The maximal fall in diastolic blood pressure was similar after the infusion (-11.40 mmHg), the oral solution (-15.20 mmHg), and the standard tablet (-12.50 mmHg). In healthy volunteers the slow release form had no significant effect on blood pressure. The concentration-effect plots showed an increasing slope in the order infusion, solution, and tablet, and anticlockwise hysteresis. This was partly due to marked heart rate counter-regulation, the corresponding mean maximal heart rate increases being 24, 19, and 17 beats·min−1.

The pronounced counter-regulation of the heart rate implies that a slow isradipine input rate would be more effective in decreasing blood pressure.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Staessen J, Lijnen P, Fagard R et al. (1989) Effects of the new calcium entry blockers isradipine (PN 200–110) in essential hypertension. J Cardiovasc Pharmacol 13: 271–276

    Google Scholar 

  2. Nelson EB, Pool JL, Taylor AA (1986) Antihypertensive activity of isradipine in humans: a new dihydropyridine calcium channel antagonist. Clin Pharmacol Ther 40: 694–697

    Google Scholar 

  3. Fitton A, Benfield P (1990) Isradipine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in cardiovascular disease. Drugs 40: 31–74

    Google Scholar 

  4. Rüegg UT, Hof RP (1990) Pharmacology of the calcium antagonist isradipine. Drugs 40 [Suppl 2]: 3–9

    Google Scholar 

  5. Kleinbloesem CH, van Brummelen P, Danhof M et al. (1986) Rate of increase in the plasma concentration of nifedipine as a major determinant of its hemodynamic effects in human. Clin Pharmacol Ther 41: 126–130

    Google Scholar 

  6. Sheiner LB, Beal SL, Sambol NC (1989) Study designs for dose-ranging. Clin Pharmacol Ther 46: 63–77

    Google Scholar 

  7. Goodman and Gilman's (1980) The pharmacological basis of therapeutics, 6th ed MacMillan, New York

    Google Scholar 

  8. Harris E, Lpool MB, Turner R (1954) 1-hydrazinophthalazine (Apresolin) in hypertension. Lancet I: 429–433

    Google Scholar 

  9. Soons PA, De Boer AG, Van Brummelen P et al. (1989) Oral absorption profile of nitrendipine in healthy subjects: a kinetic and dynamic study. Br J Clin Pharmacol 27: 179–189

    Google Scholar 

  10. Van Harten J, Van Brummelen P, Zeegers R et al. (1988) The influence of infusion rate on the pharmacokinetics and haemodynamic effects of nisoldipine in man. Br J Clin Pharmacol 25: 709–717

    Google Scholar 

  11. Abetel G, Haissly JC, Brunori A (1989) Evaluation d'un nouvel appareil tensionnel ambulatoire, le Sandoz Pressure System. Schweiz Med Wschr 119: 1786–1790

    Google Scholar 

  12. Clifton GD, Blouin RA, Dilea CS et al. (1988) The pharmacokinetics of oral isradipine in normal volunteers. J Clin Pharmacol 28: 36–42

    Google Scholar 

  13. SAS Institute (1982) SAS Users Guide: Statistics. Cary, NC, USA

  14. Kiowski W, Bertel O, Erne P et al. (1983) Haemodynamic and reflex responses to acute and chronic antihypertensive therapy with the calcium entry blocker nifedipine. Hypertension 5 [Suppl I]: 170–174

    Google Scholar 

  15. Dorward PK, Andresen MC, Burke SL et al. (1982) Rapid resetting of the aortic baroreceptors in the rabbit and its implications for short-term and longer term reflex control. Circ Res 50: 428–329

    Google Scholar 

  16. Holford NHG, Sheiner LB (1981) Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models. Clin Pharmacokinet 6: 439–453

    Google Scholar 

  17. Sumner DJ, Meredith PA, Howie CA et al. (1988) Initial blood pressure as a predictor of the response to antihypertensive therapy. Br J Clin Pharmacol 26: 715–720

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Carrara, V., Porchet, H. & Dayer, P. Influence of input rates on (±)-isradipine haemodynamics and concentration-effect relationship in healthy volunteers. Eur J Clin Pharmacol 46, 29–33 (1994). https://doi.org/10.1007/BF00195912

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00195912

Key words

Navigation